Roche looking to sell or shut down California biologic drug plant – Reuters News Agency

Date:

DealsHealth

Reuters has exclusively seen documents indicating Swiss drugmaker Roche Holding AG (ROG.S) plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029. 

Market Impact

Roche is under pressure to develop new treatments to offset the loss of billions in sales due to cheap biotech copies of its established cancer medicines Herceptin, Avastin and Rituxan.

Article Tags

Topics of Interest: DealsHealth

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Americas

Countries: SwitzerlandUnited States

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Trade deficit is not crisis, it’s investment in growth | The Express Tribune

Rising imports of industrial inputs signal economic revival, not...

William Shatner and Neil deGrasse Tyson: When stars collide

Not long ago in Seattle,...

Petrol price kept unchanged at Rs265.45 per litre for the next two weeks – SUCH TV

The federal government on Saturday kept the petrol...